BROWN MICHAEL S received a stock award from REGENERON PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001174475-26-000002
Director
Since Aug 2018
+2.12K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+155.00
Price / share
—
Trade value
—
% of position
10.0%
1/2/2026
1.55K→1.70K
Total
Net shares
+155.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +155.00 | — | — | 10.0% | 1.55K | 1.70K |
| Total | +155.00 | $0.00 | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
1.96K shares
Shares
+1.96K
Strike price
772.76
Held after
1.96K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1.96K shares | 1/2/2026 | A · Award | +1.96K | 772.76 | — | 1.96K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned6.16K
Common Stock
IndirectShares owned5K
Total
11.16K indirect11.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.16K | Indirect |
| Common Stock | 5K | Indirect |
| Total | 11.16K | 11.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported